These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16383048)

  • 1. Bisphosphonate-associated osteonecrosis of the jaws: a review of current knowledge.
    Markiewicz MR; Margarone JE; Campbell JH; Aguirre A
    J Am Dent Assoc; 2005 Dec; 136(12):1669-74. PubMed ID: 16383048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy: strategies for prevention and early recognition.
    Melo MD; Obeid G
    J Am Dent Assoc; 2005 Dec; 136(12):1675-81. PubMed ID: 16383049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe spontaneous cases of bisphosphonate-related osteonecrosis of the jaws.
    Herbozo PJ; Briones DL; Ferres AJ; Torrealba RL
    J Oral Maxillofac Surg; 2007 Aug; 65(8):1650-4. PubMed ID: 17656297
    [No Abstract]   [Full Text] [Related]  

  • 4. [Osteonecrosis of the jaw developing during bisphosphonate treatment].
    Udvardy E; Redl P; Márton I
    Magy Onkol; 2008 Mar; 52(1):81-7. PubMed ID: 18403302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonate-related osteonecrosis of the jaws.
    Yeo AC; Lye KW; Poon CY
    Singapore Dent J; 2005 Dec; 27(1):36-40. PubMed ID: 16438267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteonecrosis of the jaws and bisphosphonate treatment in cancer patients.
    Wutzl A; Eisenmenger G; Hoffmann M; Czerny C; Moser D; Pietschmann P; Ewers R; Baumann A
    Wien Klin Wochenschr; 2006 Aug; 118(15-16):473-8. PubMed ID: 16957978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Jaw avascular osteonecrosis after treatment of multiple myeloma with zoledronate.
    Lobato JV; Maurício AC; Rodrigues JM; Cavaleiro MV; Cortez PP; Xavier L; Botelho C; Hussain NS; Santos JD
    J Plast Reconstr Aesthet Surg; 2008; 61(1):99-106. PubMed ID: 18068658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma.
    Infante Cossío P; Cabezas Macián A; Pérez Ceballos JL; Palomino Nicas J; Gutiérrez Pérez JL
    Med Oral Patol Oral Cir Bucal; 2008 Jan; 13(1):E52-7. PubMed ID: 18167482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of osteonecrosis of the jaws and bisphosphonate pharmacotherapy: dental implications.
    Hay KD; Bishop PA
    N Z Dent J; 2006 Mar; 102(1):4-9. PubMed ID: 16568881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sore mandible. Bisphosphonate-associated osteonecrosis.
    Damm DD; Fantasia JE
    Gen Dent; 2006; 54(5):370, 372. PubMed ID: 17004575
    [No Abstract]   [Full Text] [Related]  

  • 11. Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment.
    Migliorati CA; Siegel MA; Elting LS
    Lancet Oncol; 2006 Jun; 7(6):508-14. PubMed ID: 16750501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: Report of 3 cases.
    Curi MM; Cossolin GS; Koga DH; Araújo SR; Feher O; dos Santos MO; Zardetto C
    J Oral Maxillofac Surg; 2007 Feb; 65(2):349-55. PubMed ID: 17236949
    [No Abstract]   [Full Text] [Related]  

  • 13. Residual (ghost) sockets in bisphosphonate use--evidence of poor healing and slow bone turnover.
    Shetty K; Bouquot J
    Gen Dent; 2009; 57(2):130-5. PubMed ID: 19552362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sunitinib and zoledronic acid induced osteonecrosis of the jaw].
    Soós B; Vajta L; Szalma J
    Orv Hetil; 2015 Nov; 156(46):1865-70. PubMed ID: 26548471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating bisphosphonate osteonecrosis of the jaws: is there a role for resection and vascularized reconstruction?
    Engroff SL; Kim DD
    J Oral Maxillofac Surg; 2007 Nov; 65(11):2374-85. PubMed ID: 17954344
    [No Abstract]   [Full Text] [Related]  

  • 16. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
    Marx RE; Sawatari Y; Fortin M; Broumand V
    J Oral Maxillofac Surg; 2005 Nov; 63(11):1567-75. PubMed ID: 16243172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.
    Migliorati CA; Schubert MM; Peterson DE; Seneda LM
    Cancer; 2005 Jul; 104(1):83-93. PubMed ID: 15929121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does avascular necrosis of the jaws in cancer patients only occur following treatment with bisphosphonates?
    Lenz JH; Steiner-Krammer B; Schmidt W; Fietkau R; Mueller PC; Gundlach KK
    J Craniomaxillofac Surg; 2005 Dec; 33(6):395-403. PubMed ID: 16253510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experiences with bisphosphonate-associated osteonecrosis of the jaws: analysis of 21 cases.
    Junquera L; Gallego L; Cuesta P; Pelaz A; de Vicente JC
    Am J Otolaryngol; 2009; 30(6):390-5. PubMed ID: 19880027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Osteonecrosis of the jaws as a possible adverse effect of the use of bisphosphonates].
    Hoefert S; Eufinger H
    Mund Kiefer Gesichtschir; 2005 Jul; 9(4):233-8. PubMed ID: 16395774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.